These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7197160)

  • 1. Properties of two urate oxidases modified by the covalent attachment of poly(ethylene glycol).
    Chen RH; Abuchowski A; Van Es T; Palczuk NC; Davis FF
    Biochim Biophys Acta; 1981 Aug; 660(2):293-8. PubMed ID: 7197160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of yeast uricase with polyethylene glycol: disappearance of binding ability towards anti-uricase serum.
    Nishimura H; Ashihara Y; Matsushima A; Inada Y
    Enzyme; 1979; 24(4):261-4. PubMed ID: 573687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of modification of amino groups with poly(ethylene glycol) on a recombinant uricase from Bacillus fastidiosus.
    Zhang C; Yang X; Feng J; Yuan Y; Li X; Bu Y; Xie Y; Yuan H; Liao F
    Biosci Biotechnol Biochem; 2010; 74(6):1298-301. PubMed ID: 20530883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved modification of yeast uricase with polyethylene glycol, accompanied with nonimmunoreactivity towards anti-uricase serum and high enzymic activity.
    Nishimura H; Matsushima A; Inada Y
    Enzyme; 1981; 26(1):49-53. PubMed ID: 7194181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopharmaceutical properties of uricase conjugated to neutral and amphiphilic polymers.
    Caliceti P; Schiavon O; Veronese FM
    Bioconjug Chem; 1999; 10(4):638-46. PubMed ID: 10411462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on antigenicity of the polyethylene glycol (PEG)-modified uricase.
    Tsuji J; Hirose K; Kasahara E; Naitoh M; Yamamoto I
    Int J Immunopharmacol; 1985; 7(5):725-30. PubMed ID: 2412977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of plasma urate levels in the cockerel with polyethylene glycol-uricase.
    Abuchowski A; Karp D; Davis FF
    J Pharmacol Exp Ther; 1981 Nov; 219(2):352-4. PubMed ID: 7288624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and preclinical studies.
    Bomalaski JS; Holtsberg FW; Ensor CM; Clark MA
    J Rheumatol; 2002 Sep; 29(9):1942-9. PubMed ID: 12233890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological properties of uricase conjugated to neutral soluble polymers.
    Caliceti P; Schiavon O; Veronese FM
    Bioconjug Chem; 2001; 12(4):515-22. PubMed ID: 11459455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and biopharmaceutical properties of PEGylated uricase.
    Freitas Dda S; Spencer PJ; Vassão RC; Abrahão-Neto J
    Int J Pharm; 2010 Mar; 387(1-2):215-22. PubMed ID: 19969053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and kinetic properties of gel entrapped urate oxidase.
    Hinberg I; O'Driscoll KF
    Biotechnol Bioeng; 1975 Oct; 17(10):1435-41. PubMed ID: 241439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic independence of some microbial urate oxidases.
    Fitzpatrick DA; McGeeney KF
    Infect Immun; 1975 Dec; 12(6):1237-41. PubMed ID: 812823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urate oxidase from the rust Puccinia recondita is a heterotetramer with two different-sized monomers.
    Aguilar M; Montalbini P; Pineda M
    Curr Microbiol; 2002 Apr; 44(4):257-61. PubMed ID: 11910495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase.
    Ganson NJ; Kelly SJ; Scarlett E; Sundy JS; Hershfield MS
    Arthritis Res Ther; 2006; 8(1):R12. PubMed ID: 16356199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereospecificity of conversion of uric acid into allantoic acid by enzymes of Canadida utilis.
    Okumura I; Kondo K; Miyake Y; Itaya K; Yamamoto T
    J Biochem; 1976 May; 79(5):1013-9. PubMed ID: 986391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of polyethylene glycol-modified uricase (PEG-uricase) to treat hyperuricemia in a patient with non-Hodgkin lymphoma.
    Chua CC; Greenberg ML; Viau AT; Nucci M; Brenckman WD; Hershfield MS
    Ann Intern Med; 1988 Jul; 109(2):114-7. PubMed ID: 3289428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupling of poly(ethylene glycol) to albumin under very mild conditions by activation with tresyl chloride: characterization of the conjugate by partitioning in aqueous two-phase systems.
    Delgado C; Patel JN; Francis GE; Fisher D
    Biotechnol Appl Biochem; 1990 Apr; 12(2):119-28. PubMed ID: 2331321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of peroxisomal catalase and urate oxidase of rat liver.
    Hayashi H
    Biochim Biophys Acta; 1979 Jun; 585(2):220-8. PubMed ID: 454682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly(ethylene glycol) and poly(N-acryloylmorpholine).
    Schiavon O; Caliceti P; Ferruti P; Veronese FM
    Farmaco; 2000 Apr; 55(4):264-9. PubMed ID: 10966157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical properties and states of sulfhydryl groups of uricase from Candida utilis.
    Nishimura H; Yoshida K; Yokota Y; Matsushima A; Inada Y
    J Biochem; 1982 Jan; 91(1):41-8. PubMed ID: 7200091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.